Miaojia Zhang
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 15
- Systemic Lupus Erythematosus Research 6
- Immunology top 10%
-
- NF-κB Signaling Pathways 6
- Hematology top 10%
-
- Cytokine Signaling Pathways and Interactions 9
-
- Bone Metabolism and Diseases 9
-
- Pulmonary Hypertension Research and Treatments 7
-
- Salivary Gland Disorders and Functions 6
-
- Adipokines, Inflammation, and Metabolic Diseases 5
- Co-authors
- Wenfeng TanLingxiao XuXiaoke FengFang WangXiaoxuan SunNan CheQiang WangYanyan Wang
- Journals
- Clinical Rheumatology (6 papers)Frontiers in Immunology (5 papers)Arthritis Research & Therapy (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Miaojia Zhang
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Rheumatology 415
- Immunology 338
- Complementary and alternative medicine 74
- Cancer Research 132
- Hematology 95
Countries citing papers authored by Miaojia Zhang
This map shows the geographic impact of Miaojia Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaojia Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaojia Zhang more than expected).
Fields of papers citing papers by Miaojia Zhang
This network shows the impact of papers produced by Miaojia Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaojia Zhang. The network helps show where Miaojia Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miaojia Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 19 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 8 | |
| 11 | 2018 | 38 | |
| 12 | 2018 | 84 | |
| 13 | 2018 | 36 | |
| 14 | 2017 | 4 | |
| 15 | 2015 | 6 | |
| 16 | 2015 | 17 | |
| 17 | 2015 | 36 | |
| 18 | 2015 | 42 | |
| 19 | 2014 | 56 | |
| 20 | 2012 | 74 |
About Miaojia Zhang
Miaojia Zhang is a scholar working on Rheumatology, Immunology and Cancer Research, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (15 papers), Cytokine Signaling Pathways and Interactions (9 papers), Bone Metabolism and Diseases (9 papers), Pulmonary Hypertension Research and Treatments (7 papers), Salivary Gland Disorders and Functions (6 papers), Systemic Lupus Erythematosus Research (6 papers), NF-κB Signaling Pathways (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Rheumatology (415 citations), Immunology (338 citations) and Complementary and alternative medicine (74 citations). Miaojia Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wenfeng Tan, Lingxiao Xu, Xiaoke Feng, Fang Wang, Xiaoxuan Sun, Nan Che, Qiang Wang, Yanyan Wang, Qian Zhang and Ju Li. Their work appears in journals such as Clinical Rheumatology, Frontiers in Immunology, Arthritis Research & Therapy, International Immunopharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.